What is the Impact Factor of Breast Cancer Research and Treatment?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Breast Cancer Research and Treatment is 3.30, ranking in quartile Q2 of Web of Science (SCIE).

Is Breast Cancer Research and Treatment indexed in Web of Science or Scopus?

Yes, Breast Cancer Research and Treatment is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.340 (Q1) and an H-index of 189.

Who publishes Breast Cancer Research and Treatment and what is the Article Processing Charge (APC)?

Breast Cancer Research and Treatment is published by Springer US. The estimated Article Processing Charge (APC) is approximately $3,524 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Breast Cancer Research and Treatment?

The official ISO-4 abbreviation of Breast Cancer Research and Treatment is "BREAST CANCER RES TR" with common acronym "brea". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q1SCImago #2,989Hybrid

Breast Cancer Research and Treatment

Acronym:brea

•

Abbreviation (ISO):BREAST CANCER RES TR

•

Identifier (ISSN):0167-6806(Print)/1573-7217(Online)

•

Publisher:Springer US

Official Website Submission Portal Compare

Clarivate IF (2026)

3.3↑ +0.3

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Breast Cancer Research and Treatment

WoS Q2

Annual Impact Factor Metric

Current (2026):3.3

Scopus SJR & RankScopus Q1

1.34

#2,989

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

189

189 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate6.7%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

398articles/year

43.85% Gold OA•91.11% Original Research

Aims & Scope

Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.

Topics Covered (Recognized by AI)

Medicine99.5%Biology99.2%Genetics98.9%Internal medicine98.3%Cancer96.7%Breast cancer94.6%Oncology58%Pathology55.3%Chemistry48%Biochemistry44.1%Surgery38.8%Mathematics30.5%Statistics26.9%Gene26.1%Endocrinology25.5%Cancer research24.8%Immunology21.6%

Primary Research Areas

Medicine Oncology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

ONCOLOGY

Rank158/333

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank151/333

IndexSCIE

Category	Index	Rank	Quartile
ONCOLOGY	JCRSCIE	158/333	Q2
ONCOLOGY	JCISCIE	151/333	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF3.3

Articles / Year200

Total Citations78

2025

IF3

Articles / Year296

Total Citations695

2024

IF3

Articles / Year382

Total Citations2,271

2023

IF3.8

Articles / Year361

Total Citations3,398

2022

IF4.624

Articles / Year378

Total Citations5,593

Year	Impact Factor	Articles / Year	Total Citations
2026	3.3	200	78
2025	3	296	695
2024	3	382	2,271
2023	3.8	361	3,398
2022	4.624	378	5,593
2021	4.872	429	7,593
2020	3.831	510	12,703
2019	3.471	423	14,021
2018	3.605	454	17,774
2017	—	535	20,129
2016	—	415	18,413
2015	—	416	17,091

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,989Scopus Q1SCImago Profile

Scopus Coverage:1981-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine

Scopus Citation Rank (SJR)Q1

1.34

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

3.48

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,524 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations3,791

3-Year Documents1,056

Citable Documents1,001

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate58.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

OncologyQ1

Cancer ResearchQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 6.7%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Breast Cancer Research and Treatment (acronym: brea, abbr: BREAST CANCER RES TR, ISSN: 0167-6806) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer US in United States since 1981. The periodical holds a Journal Impact Factor (JIF) of 3.30, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.340 (Q1), an H-index of 189.

The journal enforces rigorous peer evaluation with a publication frequency of Semimonthly, an annual output of approximately 398 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,524 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.